CliffBio
small molecule

PHENYTOIN

PHENYTOIN

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand namePHENYTOIN
Active ingredientPHENYTOIN
Strength125MG/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2004
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.